银屑病患者较高水平的高敏C反应蛋白与未来发生银屑病关节炎相关:一项前瞻性队列研究
该前瞻性队列纳入589例入组时无银屑病关节炎的银屑病患者,2006年至2019年每年由风湿科医生评估,57例发生银屑病关节炎。校正年龄、性别、银屑病严重程度与病程、甲损害、BMI、疲劳及用药后,基线高敏C反应蛋白较高与未来发生银屑病关节炎相关(HR 1.04,95%CI 1.01-1.07,P=0.007)。
要点
- 基线高敏C反应蛋白较高与银屑病患者未来发生银屑病关节炎相关(HR 1.04,95%CI 1.01-1.07,P=0.007)。
- 关节痛、肥胖及女性患者的基线高敏C反应蛋白水平显著更高。
- 高敏C反应蛋白与性别或BMI之间未发现显著交互作用,男女效应量相似。
核心结论
- 以高敏C反应蛋白水平反映的较高水平全身炎症与未来发生银屑病关节炎相关。
研究设计与样本
- 前瞻性队列研究,纳入589例入组时无银屑病关节炎的银屑病患者,2006年至2019年每年由风湿科医生评估银屑病关节炎的症状和体征。
主要发现
- 随访期间57例患者发生银屑病关节炎。
- 高敏C反应蛋白平均水平为3.1±5.5 mg/L,发生银屑病关节炎患者的高敏C反应蛋白水平为5.4±13.1 mg/L。
- 关节痛、肥胖及女性患者的基线高敏C反应蛋白水平显著更高。
- 多变量分析中,较高高敏C反应蛋白水平与未来发生银屑病关节炎相关(HR 1.04,95%CI 1.01-1.07,P=0.007)。
- 男女效应量相似,高敏C反应蛋白与性别或BMI之间未发现显著交互作用。
关键数值与推荐
- 多变量Cox比例风险模型校正年龄、性别、银屑病严重程度与病程、甲损害、BMI、疲劳及用药。
- 高敏C反应蛋白与未来发生银屑病关节炎的关联:HR 1.04(95%CI 1.01-1.07,P=0.007)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to assess whether high-sensitivity C-reactive protein (hsCRP) levels could predict the development of psoriatic arthritis (PsA) in patients with psoriasis. METHODS: We analyzed data from a prospective cohort of patients with psoriasis without PsA at enrollment. Participants were assessed annually by a rheumatologist for signs and symptoms of PsA. Information on patient demographics, psoriasis features, medications and musculoskeletal symptoms was collected. hsCRP levels were measured in serum samples collected at baseline using standard commercial assays. The association between hsCRP levels and risk of development of PsA was assessed using multivariable Cox proportional hazards model adjusted for age, sex, psoriasis severity and duration, nail lesions, body mass index (BMI), fatigue, and medication use. RESULTS: A total of 589 patients with psoriasis observed from 2006 to 2019 were analyzed. During the follow up period, 57 patients developed PsA. The mean level of hsCRP was 3.1 ± 5.5 mg/L (hsCRP levels in patients with incident PsA, 5.4 ± 13.1 mg/L). Significantly higher levels of hsCRP at baseline were found in patients with arthralgia, obesity, and in women. Higher hsCRP levels were associated with future development of PsA in multivariable analyses (hazard ratio 1.04; 95% confidence interval 1.01-1.07; P = 0.007). Similar effect size was seen in men and women. No significant interaction was found between hsCRP and sex or BMI. CONCLUSION: Higher levels of systemic inflammation, as measured by hsCRP levels, are associated with future development of PsA.
引用
- Eder L, Li X, Chandran V, et al. Association of Higher Levels of High-Sensitivity C-Reactive Protein With Future Development of Psoriatic Arthritis in Psoriasis: A Prospective Cohort Study. Arthritis Care Res (Hoboken). 2025. PMID: 40176403. doi:10.1002/acr.25539
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。